Pirfenidone for Diabetic Nephropathy

Pirfenidone is an oral antifibrotic agent that benefits diabetic nephropathy in animal models, but whether it is effective for human diabetic nephropathy is unknown. We conducted a randomized, double-blind, placebo-controlled study in 77 subjects with diabetic nephropathy who had elevated albuminuri...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sharma, Kumar, Ix, Joachim H., Mathew, Anna V., Cho, Monique, Pflueger, Axel, Dunn, Stephen R., Francos, Barbara, Sharma, Shoba, Falkner, Bonita, McGowan, Tracy A., Donohue, Michael, RamachandraRao, Satish, Xu, Ronghui, Fervenza, Fernando C., Kopp, Jeffrey B.
Format: Artigo
Langue:Inglês
Publié: American Society of Nephrology 2011
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103734/
https://ncbi.nlm.nih.gov/pubmed/21511828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010101049
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires